4D Molecular Therapeutics, Inc. (FDMT)
Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
10. 70
-0.49
-4.38%
$
513.26M Market Cap
- P/E Ratio
0% Div Yield
485,634 Volume
-3.06 Eps
$ 11.19
Previous Close Day Range
10.67 11.5
Year Range
2.23 12.34
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 82 days
| FDMT 4D Molecular Therapeutics, Inc. 27 Feb 2026 (In 2 months) | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 12 Nov 2025 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 10 Nov 2025 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 5 Nov 2025 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 7 Aug 2025 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 7 May 2025 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 26 Feb 2025 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 7 Nov 2024 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 7 Aug 2024 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 21 May 2024 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 29 Feb 2024 | | - Cons. EPS | - EPS |
| FDMT 4D Molecular Therapeutics, Inc. 7 Nov 2023 | | - Cons. EPS | - EPS |
FDMT Earnings Reports FAQ
What is the earnings per share (EPS) for FDMT?
The current EPS is -3.06.
What is the company's earnings growth rate?
4D Molecular Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-27, based on the FDMT's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for 4D Molecular Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for FDMT at this time, as 4D Molecular Therapeutics, Inc has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
